Here are three stocks with buy rank and strong income characteristics for investors to consider today, December 13th:
AGNC Investment Corp. (AGNC): This real estate investment trust has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
AGNC Investment Corp. Price and Consensus
AGNC Investment Corp. price-consensus-chart | AGNC Investment Corp. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 11.00%, compared with the industry average of 8.45%. Its five-year average dividend yield is 11.82%.
AGNC Investment Corp. Dividend Yield (TTM)
AGNC Investment Corp. dividend-yield-ttm | AGNC Investment Corp. Quote
Apollo Investment Corporation (AINV): This business development company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Apollo Investment Corporation Price and Consensus
Apollo Investment Corporation price-consensus-chart | Apollo Investment Corporation Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 10.39%, compared with the industry average of 8.54%. Its five-year average dividend yield is 11.45%.
Apollo Investment Corporation Dividend Yield (TTM)
Apollo Investment Corporation dividend-yield-ttm | Apollo Investment Corporation Quote
The Buckle, Inc. (BKE): This lifestyle retailer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.2% over the last 60 days.
Buckle, Inc. (The) Price and Consensus
Buckle, Inc. (The) price-consensus-chart | Buckle, Inc. (The) Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.77%, compared with the industry average of 0.00%. Its five-year average dividend yield is 4.11%.
Buckle, Inc. (The) Dividend Yield (TTM)
Buckle, Inc. (The) dividend-yield-ttm | Buckle, Inc. (The) Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Buckle, Inc. (The) (BKE) : Free Stock Analysis Report
Apollo Investment Corporation (AINV) : Free Stock Analysis Report
AGNC Investment Corp. (AGNC) : Free Stock Analysis Report
To read this article on Zacks.com click here.